|Titre :||A European community pharmacy-based survey to investigate patterns of prescription fraud through identification of falsified prescriptions (2014)|
|Auteurs :||M. LAPEYRE-MESTRE ; M. GONY ; A. CARVAJAL ; D. MACIAS ; A. CONFORTI ; P. D'INCAU ; R. HEERDINK ; R. VAN DER STICHELE ; U. BERGMAN ; The OSIAP Europe Study Group|
|Type de document :||Article : Périodique|
|Dans :||European Addiction Research (Vol.20, n°4, June 2014)|
|Article en page(s) :||174-182|
|Discipline :||EPI (Epidémiologie / Epidemiology)|
Thésaurus géographiqueEUROPE ; BELGIQUE ; FRANCE ; ITALIE ; PAYS-BAS ; ESPAGNE ; SUEDE
Thésaurus mots-clésPRESCRIPTION MEDICALE ; MESUSAGE ; PHARMACIE ; OPIOIDES ; STIMULANTS ; PSYCHOTROPES ; BENZODIAZEPINES ; METHYLPHENIDATE ; BUPRENORPHINE ; ORDONNANCE FALSIFIEE ; ENQUETE
Aim: To identify prescription drugs involved in falsified prescriptions in community pharmacies in 6 European countries.
Methods: A cross-sectional survey among 2,105 community pharmacies in Belgium, France, Italy, the Netherlands, Spain and Sweden was carried out to collect all suspect prescription forms. For each reported drug, the number of reported falsified prescriptions per thousand inhabitants was estimated. A falsification ratio was calculated by dividing the number of reports by the number of defined daily doses per 1,000 inhabitants per day for this drug, computed from national sale or reimbursement data.
Results: On 862 prescription forms, benzodiazepines (zolpidem, bromazepam, alprazolam), buprenorphine (as an opioid maintenance drug) and tramadol were the most frequently reported. Depending on their level of use in each country, methylphenidate, morphine and flunitrazepam presented the highest falsification ratios, particularly in Spain, Belgium and France.
Conclusions: Stimulants, opioids and some benzodiazepines were the most frequently reported drugs in this survey on falsified prescriptions, but differences between countries were observed. (c) 2014 S. Karger AG, Basel.
|Domaine :||Autres substances / Other substances|
|Refs biblio. :||54|
|Affiliation :||University of Toulouse UMR INSERM 1027, CEIP-Addictovigilance, Service de Pharmacologie Médicale et Clinique, CHU, Toulouse, France|